Paperpal Prime Logo

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : Impact Factor & More

eISSN: 1756-9966pISSN: 1756-9966
JournalOpen Access

Key Metrics

Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Oncology
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2890 | USD 3490 | GBP 2490
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorRegina Elena National Cancer Institute
FrequencyContinuous publication
Publication Start Year1982
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Retraction Note: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through.
  • 8 Aug 2026
  • Journal of experimental & clinical cancer research : CR
Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance
  • 5 Aug 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model
  • 28 Jul 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Tailored Fc\u03b3R blockade enhances immune checkpoint therapy and overcomes resistance
  • 25 Jul 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Correction: PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma
  • 23 Jul 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Soulangianolide A targets FAM120A to disrupt SREBP1-driven lipid metabolic reprogramming and suppress clear cell renal cell carcinoma.
  • 17 Jul 2026
  • Journal of experimental & clinical cancer research : CR
Retraction Note: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through.
  • 8 Aug 2026
  • Journal of experimental & clinical cancer research : CR
Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance
  • 5 Aug 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model
  • 28 Jul 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Tailored Fc\u03b3R blockade enhances immune checkpoint therapy and overcomes resistance
  • 25 Jul 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Correction: PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma
  • 23 Jul 2026
  • Journal of Experimental & Clinical Cancer Research : CR
Soulangianolide A targets FAM120A to disrupt SREBP1-driven lipid metabolic reprogramming and suppress clear cell renal cell carcinoma.
  • 17 Jul 2026
  • Journal of experimental & clinical cancer research : CR

FAQs on JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH